Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial

Mia M. Pries-Heje, Christoffer Wiingaard, Nikolaj Ihlemann, Sabine U. Gill, Niels E. Bruun, Hanne Elming, Jonas A. Povlsen, Trine Madsen, Kaare T. Jensen, Kurt Fursted, Martin Schultz, Lauge Østergaard, Jens J. Christensen, Ulrik Christiansen, Flemming Rosenvinge, Jannik Helweg-Larsen, Emil L. Fosbøl, Lars Køber, Christian Torp-Pedersen, Niels TønderClaus Moser, Kasper Iversen, Henning Bundgaard*

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

2 Citations (Scopus)
Original languageEnglish
JournalThe New England Journal of Medicine
Volume386
Issue number6
Pages (from-to)601-602
Number of pages2
ISSN0028-4793
DOIs
Publication statusPublished - 10 Feb 2022

Keywords

  • Administration, Intravenous
  • Administration, Oral
  • Anti-Bacterial Agents/administration & dosage
  • Endocarditis, Bacterial/drug therapy
  • Follow-Up Studies
  • Humans
  • Treatment Outcome

Cite this